SO
ABCL icon

STRS Ohio’s AbCellera Biologics ABCL Stock Holding History

STRS Ohio’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-106,000
Closed -$799K – 1928
2023
Q1 		$799K Buy
106,000
+12,600
+13% +$114K ﹤0.01% 1041
2022
Q4 		$946K Sell
93,400
-6,400
-6% -$73.9K ﹤0.01% 958
2022
Q3 		$987K Buy
99,800
+51,600
+107% +$566K ﹤0.01% 912
2022
Q2 		$513K Buy
+48,200
New +$408K ﹤0.01% 1341

Other funds holding ABCL

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

STRS Ohio's ABCL Position: Q2 2023 in Review

STRS Ohio sold out of AbCellera Biologics (ABCL) in Q2 2023, closing a stake of 106,000 shares — an estimated $799K sold.

STRS Ohio first reported a position in ABCL in Q2 2022 and held it in 4 quarters. The position peaked at $987K in Q3 2022. 169 funds tracked by Wall St. Rank hold ABCL as of Q2 2023.

  • STRS Ohio reported no remaining AbCellera Biologics position as of Q2 2023 after selling out during the quarter.
  • STRS Ohio sold 106,000 AbCellera Biologics shares in Q2 2023, an estimated $799K.
  • STRS Ohio first reported a position in AbCellera Biologics in Q2 2022 and held it in 4 quarters.
  • STRS Ohio's AbCellera Biologics position peaked at $987K in Q3 2022.
  • 169 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2023.

Based on STRS Ohio's 13F filing for Q2 2023, filed 31 Jul 2023.